Published in
BioMed Central, BMC Nephrology, 1(16), 2015
DOI: 10.1186/s12882-015-0089-2
Links
- ORCID
- ORCID
- BioMed Central | PDF
- [espace.library.uq.edu.au]
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications
Journal article published in 2015 by
Andrea K. Viecelli,
Elaine Pascoe,
Kevan R. Polkinghorne,
Carmel Hawley,
Peta-Anne Paul-Brent,
Sunil V. Badve,
Alan Cass 
,
Stephane Heritier,
Peter G. Kerr,
Trevor A. Mori ,
Amanda Robertson,
Hooi L. Seong,
Ashley B. Irish
,
Stephane Heritier,
Peter G. Kerr,
Trevor A. Mori ,
Amanda Robertson,
Hooi L. Seong,
Ashley B. Irish
This paper is made freely available by the publisher.
Full text: Download
Data provided by 